Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study

H Yu, L Lin, Z Zhang, H Zhang, H Hu - Signal transduction and targeted …, 2020 - nature.com
NF-κB pathway consists of canonical and non-canonical pathways. The canonical NF-κB is
activated by various stimuli, transducing a quick but transient transcriptional activity, to …

NF‐κB signaling in inflammation and cancer

T Zhang, C Ma, Z Zhang, H Zhang, H Hu - MedComm, 2021 - Wiley Online Library
Since nuclear factor of κ‐light chain of enhancer‐activated B cells (NF‐κB) was discovered
in 1986, extraordinary efforts have been made to understand the function and regulating …

Signaling via the NFκB system

S Mitchell, J Vargas, A Hoffmann - … Reviews: Systems Biology …, 2016 - Wiley Online Library
The nuclear factor kappa B (NFκB) family of transcription factors is a key regulator of immune
development, immune responses, inflammation, and cancer. The NFκB signaling system …

Clinical significance of FBXW7 loss of function in human cancers

J Fan, M Bellon, M Ju, L Zhao, M Wei, L Fu, C Nicot - Molecular cancer, 2022 - Springer
Abstract FBXW7 (F-Box and WD Repeat Domain Containing 7)(also referred to as FBW7 or
hCDC4) is a component of the Skp1-Cdc53/Cullin-F-box-protein complex (SCF/β-TrCP). As …

Ubiquitin ligases in oncogenic transformation and cancer therapy

D Senft, J Qi, ZA Ronai - Nature Reviews Cancer, 2018 - nature.com
The cellular response to external stress signals and DNA damage depends on the activity of
ubiquitin ligases (E3s), which regulate numerous cellular processes, including homeostasis …

Mechanisms and function of substrate recruitment by F-box proteins

JR Skaar, JK Pagan, M Pagano - Nature reviews Molecular cell biology, 2013 - nature.com
S phase kinase-associated protein 1 (SKP1)–cullin 1 (CUL1)–F-box protein (SCF) ubiquitin
ligase complexes use a family of F-box proteins as substrate adaptors to mediate the …

Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities

RJ Davis, M Welcker, BE Clurman - Cancer cell, 2014 - cell.com
Tumor suppressors with widespread impact on carcinogenesis control broad spectra of
oncogenic pathways. Protein degradation is an emerging mechanism by which tumor …

SCF ubiquitin ligase-targeted therapies

JR Skaar, JK Pagan, M Pagano - Nature reviews Drug discovery, 2014 - nature.com
The clinical successes of proteasome inhibitors for the treatment of cancer have highlighted
the therapeutic potential of targeting this protein degradation system. However, proteasome …

DNA damage-induced transcription stress triggers the genome-wide degradation of promoter-bound Pol II

B Steurer, RC Janssens, ME Geijer… - Nature …, 2022 - nature.com
The precise regulation of RNA Polymerase II (Pol II) transcription after genotoxic stress is
crucial for proper execution of the DNA damage-induced stress response. While stalling of …

[HTML][HTML] The ubiquitin proteasome system—implications for cell cycle control and the targeted treatment of cancer

F Bassermann, R Eichner, M Pagano - Biochimica et Biophysica Acta (BBA) …, 2014 - Elsevier
Two families of E3 ubiquitin ligases are prominent in cell cycle regulation and mediate the
timely and precise ubiquitin–proteasome-dependent degradation of key cell cycle proteins …